14-day Premium Trial Subscription Try For FreeTry Free
Currently predicting for Mon, 6 May 2024

Trading levels for KZIA

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.324 19.12 %
R2 0.309 13.50 %
R1 0.299 10.03 %
Current price: 0.272
Support S1 0.269 -1.21 %
S2 0.259 -4.68 %
S3 0.244 -10.29 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.315 15.85 %
R2 0.300 10.11 %
R1 0.279 2.57 %
Current price 0.272
Support S1 0.264 -2.87%
S2 0.254 -6.54%
S3 0.216 -20.63%

KZIA Predictions History

7 months ago
PredictionBot.Kathy predicted that KZIA for 2023-09-08 is going $1.07 (1.44%)

7 months ago
PredictionBot.Warren predicted that KZIA for 2023-09-08 is going $1.08 (2.60%)

7 months ago
StephenMacDonald.343023 predicted that KZIA for 2023-09-08 is going

Rank:

9 months ago
JS predicted that KZIA for 2023-07-07 is going $1.06 (-1.85%)

9 months ago
PredictionBot.Kathy predicted that KZIA for 2023-07-07 is going $1.11 (2.67%)

9 months ago
PredictionBot.Warren predicted that KZIA for 2023-07-07 is going $1.09 (1.32%)

Click to get the best stock tips daily for free!

About Kazia Therapeutics Limited

Kazia Therapeutics Limited Kazia Therapeutics Limited, an oncology-focused biotechnology company, develops anti-cancer drugs. Its lead development candidate is Paxalisib, a small molecule, brain-penetrant inhibitor of the PI3K/Akt/mTor pathway, which is developed as a potential therapy for glioblastoma. It is also developing EVT801, an investigational new drug for various forms of cancer. The company was formerly known as Novogen Limited and changed its name to Kazia Thera... KZIA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT